Plasmonic Gold Nanostar-Mediated Photothermal Immunotherapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunotherapy

Background:

• Cancer remains a leading global cause of mortality, necessitating advanced detection and treatment strategies.
• Gold nanoparticles (GNP) show promise for cancer therapy, particularly with photothermal effects and immunotherapy.
• Gold nanostars (GNS) possess unique structures enhancing light absorption and photothermal heating for cancer treatment.

Purpose of the Study:

• To highlight the development and application of GNS-mediated therapy for cancer treatment.
• To present experimental results demonstrating the efficacy of GNS in photothermal therapy.
• To explore the potential of GNS in combination with immunotherapy for enhanced anti-cancer effects.

Main Methods:

• Utilizing gold nanostars (GNS) for photothermal therapy.
• Investigating the synergistic effects of GNS photothermal therapy with immune checkpoint inhibitors.
• Developing Synergistic Immuno Photo Nanotherapy (SYMPHONY) for cancer treatment.

Main Results:

• GNS exhibit superior light absorption and photothermal heating capabilities.
• The photothermal effect of GNS amplifies anti-tumor immune responses.
• SYMPHONY effectively reverses tumor-mediated immunosuppression, leading to durable immunity.
• SYMPHONY demonstrated efficacy against primary tumors and cancer metastasis in experimental studies.

Conclusions:

• GNS-mediated photothermal therapy, particularly within the SYMPHONY framework, presents a highly selective and less invasive cancer treatment approach.
• The combination of GNS photothermal effects and immunotherapy holds significant potential for overcoming tumor-induced immunosuppression and establishing long-lasting anti-cancer immunity.
• Experimental findings underscore the superior performance of GNS for advanced cancer photothermal treatment applications.